@article{78ca390b11dc4bcd950cbe825de21fce,
title = "Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse",
keywords = "Glasdegib maintenance therapy in patients at high risk for relapse did not meaningfully reduce relapse incidence., Key points posttransplantation, Use of glasdegib in the posttransplantation setting was complicated by adverse events requiring drug holds and occasional discontinuation",
author = "Andrew Kent and Sumithira Vasu and Derek Schatz and Natalie Monson and Steven Devine and Clayton Smith and Gutman, \{Jonathan A.\} and Pollyea, \{Daniel A.\}",
note = "Funding Information: This study was supported by the Leukemia and Lymphoma Society{\textquoteright}s Therapy Acceleration Program and Pfizer.",
year = "2020",
month = jul,
day = "14",
doi = "10.1182/bloodadvances.2020001991",
language = "English",
volume = "4",
pages = "3102--3108",
journal = "Blood Advances",
issn = "2473-9529",
number = "13",
}